Recent News for XFOR - X4 Pharmaceuticals, Inc.

Date	Title
May 29	X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinical Data from Ongoing Phase 2 Trial in Chronic Neutropenia